NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biopharmaceutical Research Company

Biopharmaceutical Research Company

Private
Castroville, CaliforniaHealthcare & Life Scienceshttps://brctherapeutics.com/

Last Round

Series A

Oct 4, 2022

Total Funding Raised

$23M

Company Overview

Biopharmaceutical Research Company is a biopharmaceutical and cannabis testing company specializing in plant-based therapeutics and providing comprehensive analysis for potency, contaminant testing, and stability data to support research on treatments for post-traumatic stress disorder, chronic pain, and other conditions affecting patients and veterans.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain, Compliance

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

cannabis researchDEA-compliant cannabiscannabinoid therapeuticsclinical trial supplyresearch-grade cannabiscannabis supply chainanalytical testingcGMP manufacturingregulatory compliancecontrolled substancesweed researchcannabis pharmadrug developmentterpene profilingcannabinoid profiling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biopharmaceutical Research Company Comparables

Compare Biopharmaceutical Research Company with similar companies based on industry and business-model similarity.

Biopharmaceutical Research Company comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Groff North America
84%
Maridose LLC
83%
Royal Emerald Pharmaceuticals
80%

Biopharmaceutical Research Company Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 4, 2022
Convertible DebtOct 2, 2020

Biopharmaceutical Research Company Investors

Notable investors and investment history

Biopharmaceutical Research Company investors
InvestorRounds
Achari VenturesSeries A
Intrinsic Capital PartnersSeries A
Delta Emerald VenturesSeries A
AFI Capital PartnersSeries A
Argonautic VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2025

    Dr. Stephen Wright joins as Advisor in Drug Development.

Biopharmaceutical Research Company Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biopharmaceutical Research Company Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biopharmaceutical Research Company's valuation, stock price, and market status.

Firmographic Details

HeadquartersCastroville, California
Year Founded2017
Last FundingOct 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.